Cloning, expression, identification and bioinformatics analysis of Rv3265c gene fromMycobacterium tuberculosis inEscherichia coli

• Published in: 亚太热带医药杂志（英文版） 2011 (4), p.266-270
• Main Authors: Qiang Wu, Peng Zhou, Shiyun Qian, Xi Qin, Zhigang Fan, Qiongyao Fu, Zhinong Zhan, Hua Pei
• Format: Article
• Language: English
• ISSN: 1995-7645

Objective:To clone and express Rv3265c gene ofMycobacterium tuberculosis inEscherichia coli (E. coli)under optimistic conditions, obtain and identify protein expressed, analyze the structure and characteristics of the protein using bioinformatics methods for future applications.Methods:Rv3265c gene fromMycobacterium tuberculosisH37Rv was amplified by polymerase chain reaction, and was cloned into the pET-30a vector after purification and recovery. The recombinant plasmid was sequenced and expressed inE. coliBL21(DE3), and then purified and identified by western blotting. The essential physical-chemical properties of the protein were predicated by bioinformatics tools, including subcellular location, secondary structure, domains, antigenic epitopes,etc. Tertiary structure of the protein based on homology modeling was established, while multi-sequence homological alignment and phylogenetic analysis were proformed.Results: The recombinant protein was obtained in soluble fraction from expression system inE.coliBL21(DE3) carrying pET30- Rv3265c plasmid, and Rv3265c gene was expressed correctly. Bioinformatics analysis showed the protein contained no signal peptide and transmembrane helices, located outside of membrane. Secondary structure analysis revealed it contained α-helix, extended strand and random coil,46.8%, 14.6%, 38.6%, respectively. Furthermore, it possessed six potential antigenic epitopes, one glycosyl transferase domain. A simple three-dimensional model of this protein was constructed by Swiss-model sever. Both sequences and structures were conservative and especial either in gene or in protein.Conclusions: Rv3265c gene might be a desirable molecular target for anti-tuberculosis drug and vaccine. The purified protein from expression will be utilized to study the kinetics of L-rhamnosyltransferase and to develope an enzyme assay for screening vaccine or drug.